OncoMatch

OncoMatch/Clinical Trials/NCT07799974

Identification of Changes in Cancer-related Fatigue and Physical Activity and Their Association in Patients With Inoperable Lung Cancer: a Longitudinal Observational Study

Is NCT07799974 recruiting? Yes, currently enrolling (Oct 2026).

RecruitingUniversity Hospital, GhentNCT07799974Data as of Oct 2026Location: Belgium

The goal of this observational study is to learn how fatigue changes during lung cancer treatment and how it relates to physical activity levels in adults with locally advanced, inoperable, or metastatic lung cancer who are starting chemotherapy and/or immunotherapy. The main questions to answer are: * How do fatigue and physical activity levels change throughout lung cancer treatment? * How are changes in fatigue related to physical activity levels on the short- and long term? Participants will: * Complete questionnaires on fatigue, breathlessness, sleep quality, quality of life, stress, anxiety and depression at multiple time points. * Wear activity monitors during four measurement periods to assess daily physical activity. * Complete brief daily smartphone questionnaires on fatigue, breathlessness, pain, and perceived ability to walk. * Wear a smartwatch throughout the study. * Undergo physical assessments, including a 1-minute sit-to-stand test, a thigh muscle strength test, and a frailty assessment. * Attend six study visits over the course of the study, some of which may be scheduled alongside routine hospital appointments.

Check if I qualify

Extracted eligibility criteria

Cancer type

Non-Small Cell Lung Carcinoma

Small Cell Lung Cancer

Performance status

ECOG 0–2(Ambulatory, capable of self-care)

Prior therapy

No prior treatment (treatment-naive required)

Cannot have received: targeted therapy

treatment with targeted therapies (mostly tyrosine kinase inhibitors (TKI's))

Structured fields extracted by AI. May contain errors — verify against the official protocol.

Frequently asked questions

Is NCT07799974 currently recruiting?

Yes, this trial is currently recruiting patients.

Can patients have received prior systemic therapy?

No. This trial requires treatment-naive patients — prior systemic therapy is an exclusion criterion.

Could you qualify for this trial?

Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.

Check if I qualify